Nordic Nanovector ASA | Key People and Executives
Joanna C. Horobin
Independent Non-Executive Director
Jean-Pierre Bizzari
Independent Director
Gisela M. Schwab
Independent Director
Per Anders Göte Samuelsson
Independent Director
Hilde Hermansen Steineger
Independent Director
Eduardo Bravo Fernández de Araoz
Chief Executive Officer
Marco Renoldi
Co-Chief Operating Officer
Anniken Hagen
Co-COO & Chief Technical Officer
Tone Kvåle
Chief Financial Officer & Director
Lisa Rojkjaer
Chief Medical Officer
Jostein Dahle
Chief Scientific Officer
Arne Kolstad
Member-Scientific Advisory Board
Maureen Deehan
Head-Corporate Development & Strategy
Rosemarie Corrigan
Chief Quality Officer
Reza Safaei
Head-Medical Affairs
Malene Brondberg
VP-Investor Relations & Corporate Communications
Rita Dege
Chief Human Resources Officer
Joanna C. Horobin
Independent Non-Executive Director
Jean-Pierre Bizzari
Independent Director
Gisela M. Schwab
Independent Director
Per Anders Göte Samuelsson
Independent Director
Hilde Hermansen Steineger
Independent Director
| Address |
Kjelsasveien 168 B
Oslo PS 0884
Norway
|
|
Employees
|
- |
| Website |
http://www.nordicnanovector.com |
| Updated |
07/08/2019 |
| Nordic Nanovector ASA engages in the provision of development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers such as non-Hodgkin's Lymphoma and leukaemia. It offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. Nordic Nanovector operates its business through the following geographical segments: Norway, Switzerland, and the United Kingdom. |
